Findings from IL-33−/− and ST2−/− mouse models of postmenopausal osteoporosis revealed that IL-33 and its receptor protects the maxilla and femur from bone loss during physiological bone remodeling. The gene discussed is IL1RL1; the disease is osteoporosis.